Resources from the same session
O-15: Randomized, Phase 3 study of second-line tislelizumab vs chemotherapy in advanced or metastatic esophageal squamous cell carcinoma (RATIONALE 302) in the overall population and Europe/North America subgroup
Presenter: Jaffer Ajani,
Session: Session X: Esophageal and Gastric Cancers
Resources:
Webcast
LBA-5: Phase Ib study of the anti-TIGIT antibody tiragolumab in combination with atezolizumab in patients with metastatic esophageal cancer
Presenter: Zev Wainberg, United States
Session: Session X: Esophageal and Gastric Cancers
Resources:
Webcast
Discussant: LBA-4, Selected Oral Abstract, LBA-5
Presenter: Kei Muro, Japan
Session: Session X: Esophageal and Gastric Cancers
Resources:
Webcast
Checkpoint Inhibition in Esophageal Cancer
Presenter: David Ilson, United States
Session: Session X: Esophageal and Gastric Cancers
Resources:
Webcast
Checkpoint Inhibition in Gastric Cancer
Presenter: Markus Moehler, Germany
Session: Session X: Esophageal and Gastric Cancers
Resources:
Webcast
O-13: Gut microbiome to predict survival time in advanced gastric cancer treated with nivolumab: the DELIVER trial (JACCRO GC-08)
Presenter: Yu Sunakawa, Japan
Session: Session X: Esophageal and Gastric Cancers
Resources:
Webcast
O-14: Exploratory biomarker analysis of trastuzumab deruxtecan in DESTINY-Gastric01, a randomized, phase 2, multicenter, open-label study in patients with HER2-positive or -low advanced gastric or gastroesophageal junction adenocarcinoma
Presenter: Kohei Shitara, Japan
Session: Session X: Esophageal and Gastric Cancers
Resources:
Webcast
SO-31: ASPEN-01: A Phase 1 study of ALX148, a CD47 blocker, in combination with trastuzumab, ramucirumab and paclitaxel in patients with 2nd line HER2-positive advanced gastric or gastroesophageal junction (G/GEJ) cancer
Presenter: Hyun Cheol Chung,
Session: Session X: Esophageal and Gastric Cancers
Resources:
Webcast
Discussant: O-13, O-14, SO-31
Presenter: Yelena Janjigian, United States
Session: Session X: Esophageal and Gastric Cancers
Resources:
Webcast
New Agents on the Horizon in Esophageal and Gastric Cancer
Presenter: Daniel Catenacci, United States
Session: Session X: Esophageal and Gastric Cancers
Resources:
Webcast